home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login »

news

Tag: 2014

Dec15Nevro Announces First Draw Down of $20 Million Under Term Loan Facility with CRG »


Menlo Park, Calif., December 15, 2014 – Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, is...

Read More »

Dec10Good Start Genetics, IviGen and Igenomix Announce Exclusive Relationship in Reproductive Testing »


-- Partner on Expansive Suite of Advanced, Genetics-based Products to Manage Infertility --   CAMBRIDGE, Mass. and VALENCIA, Spain, December 10, 2014 -- Good Start Genetics®, Inc., a commercial-stage molecular...

Read More »

Dec8NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater Insight into Probability of Breast Cancer Recurrence Between Year 5 and 10 After Diagnosis »


-- The Prosigna Score Provides Important Information for Node-Negative and Node-Positive (1-3 Nodes) Breast Cancer Patients in the First 5 Years and 5 to 10 Years After Diagnosis --   SEATTLE--(BUSINESS WIRE...

Read More »

Dec4Corium Announces Closing Of Expanded Term Loan Facility With CRG »


MENLO PARK, Calif., December 4, 2014 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it...

Read More »

Nov10TriVascular Technologies, Inc. and CRG LP Amend and Restate Term Loan Facility »


Santa Rosa, CA, November 10, 2014 – TriVascular Technologies, Inc. (Nasdaq: TRIV) and CRG LP (formerly known as Capital Royalty) and its affiliate funds (“CRG”) today announced that they...

Read More »

Nov10NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate »


-- Category I CPT Codes Will Expand Patient Access to Novel Treatment for Common Condition that Significantly Impacts Quality of Life --     PLEASANTON, Calif. – November 10, 2014 – NeoTract,...

Read More »

Oct30Blue Belt Technologies Closes $40 Million in Debt Financing from CRG »


MINNEAPOLIS – October 30, 2014 - Blue Belt Technologies, Inc. and CR Group (“CRG”) announced that they have closed a senior secured term loan for up to $40 million of...

Read More »

Oct15TriVascular Announces FDA Approval of CustomSeal(TM) Technology for the Ovation Prime(R) System »


-- Customized Sealing Technology Enables Faster Procedure Times, Preserves the Aortic Neck and Provides an Optimized Seal Tailored to Each Patient's Specific Anatomy --   SANTA ROSA, Calif., Oct. 15, 2014 ...

Read More »

Oct9Astute Medical And CRG Announce FDA Milestone Under Term Loan Agreement »


SAN DIEGO – October 9, 2014 - Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG....

Read More »

Sep9Biodesix Receives Highmark Blue Cross Blue Shield Coverage for VeriStrat Test »


-- Lung cancer diagnostic deemed medically necessary to guide treatment decisions –   Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced that its VeriStrat...

Read More »

May19AFT Pharmaceuticals Closes Important Financing To Spur Global Growth »


May 19, 2014 – Innovative Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised an equity and structured debt funding package with Capital Royalty Partners (Houston, Boulder, New York)...

Read More »

May6NanoString Technologies Receives Canadian Market Approval for its Prosigna Breast Cancer Prognostic Gene Signature Assay »


-- The Prosigna Assay on the nCounter Dx Analysis System Provides Compelling Clinical Data, Clear Patient Report, and Localized Processing in Qualified Canadian Labs --   SEATTLE--(BUSINESS WIRE)--...

Read More »

Apr29TriVascular Announces FDA-Approved Expansion of Ovation® and Ovation Prime™ Indication Statements »


-- More Patients Now Have Access to a Less Invasive, On-Label, Clinically Proven Endovascular Aortic Repair (EVAR) Solution --   SANTA ROSA, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. ...

Read More »

Apr22TriVascular Technologies, Inc. Announces the Closing of Its Initial Public Offering »


SANTA ROSA, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime™ Abdominal Stent Graft System, today announced the closing of its initial public...

Read More »

Apr9Tandem Diabetes Care and Capital Royalty Amend and Restate Term Loan Facility »


SAN DIEGO, CA – April 9, 2014 – Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) and Capital Royalty Partners II, L.P. and its affiliate funds (“Capital Royalty”) today announced...

Read More »

Apr3NanoString Technologies Announces $45 Million Term Loan Agreement with Capital Royalty »


SEATTLE, Washington – April 3, 2014 – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into...

Read More »

Mar17Good Start Genetics Announces Collaboration with PerkinElmer to Bring GoodStart Select ™ Carrier Screening Tests to Broader Women’s Health Market »


-- Agreement Will Greatly Expand Access to Reproductive Health Community --   CAMBRIDGE, Mass., March 17, 2014 - Good Start Genetics®, Inc., an innovative molecular genetic information company, today announced a...

Read More »

Mar3RainDance Technologies Closes Series E Financing with GE »


-- GE Ventures support RainDance’s vision to make liquid biopsy a commercial reality --   BILLERICA, Mass. – March 3, 2014 – RainDance Technologies, Inc., an innovative genomics tools company...

Read More »

Mar3Biodesix Receives CE Mark for VeriStrat Specimen Collection and Shipping Kit »


-- Blood-based protein diagnostic predicts differential treatment outcomes for non-small cell lung cancer --   Mar 3, 2014 - Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today...

Read More »

Jan13Good Start Genetics Announces Contract with Tufts Health Plan to Cover GoodStart Select ™ Carrier Screening Test »


CAMBRIDGE, Mass., January 13, 2014 -- Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced that the company has signed...

Read More »

Jan10Biodesix and Capital Royalty Close Financing Transaction »


BOULDER, Colorado – January 10, 2014 – Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the company closed a structured debt financing with Capital Royalty...

Read More »